title: Colesevelam hydrochloride does not cause maternal or fetal toxicity in rats and rabbits.
abstract: WelChol (colesevelam hydrochloride), a bile acid sequestrant for the treatment of hypercholesterolemia, was evaluated for adverse effects on reproduction and fetal development using standard preclinical tests. During gestation, Sprague-Dawley rats used in the developmental toxicity study received feed, feed/control article or feed plus 300, 1,000 or 3,000 mg/kg/day colesevelam whereas rats in the pre- and postnatal toxicity study received vehicle or 100, 300 or 1,000 mg/kg/day colesevelam via gavage. New Zealand white rabbits received control or 100, 500 or 1,000 mg/kg/day colesevelam via gavage. No deaths, premature deliveries or gross pathologic lesions were observed up to gestation day (GD) 20 for rats and GD 28 for rabbits. No significant differences in the number of pregnant animals, average litter size, percentage of viable fetuses, fetal body weights, number of corpora lutea, fetal viability, or gross malformations were observed versus controls. Pre- and postnatal effects were assessed in pregnant rats receiving 100, 300 or 1,000 mg/kg/day colesevelam from GD 6 to postpartum day 22. Gestation, parturition and lactation in F(0) generation dams were similar between treatment and control groups. Colesevelam did not affect physical or neurological development or induce gross pathological changes in F(1) generation rats. Colesevelam does not produce developmental toxicity in rats or rabbits, nor does it exhibit pre- or postnatal toxicity in rats at the tested doses.
authors.affiliation: Genzyme Drug Discovery and Development, 153 Second Avenue, Waltham, MA 05451, USA. judith.marquis@genzyme.com
authors.forename: Judith K
authors.initials: JK
authors.lastname: Marquis
authors.forename: Rafif
authors.initials: R
authors.lastname: Dagher
authors.forename: Brian A
authors.initials: BA
authors.lastname: Baker
authors.forename: Michael R
authors.initials: MR
authors.lastname: Jones
mesh_terms: D000499:Allylamine / Q000031:analogs & derivatives* / Q000633:toxicity; D000818:Animals; D000831:Animals, Newborn; D000924:Anticholesteremic Agents / Q000633:toxicity*; D001724:Birth Weight / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D000069472:Colesevelam Hydrochloride; D004435:Eating / Q000187:drug effects; D005260:Female; D005333:Fetus / Q000187:drug effects* / Q000473:pathology; D006128:Growth / Q000187:drug effects; D008297:Male; D008425:Maternal Behavior / Q000187:drug effects; D011247:Pregnancy; D011817:Rabbits; D051381:Rats; D017207:Rats, Sprague-Dawley; D012098:Reproduction / Q000187:drug effects
chemical_list: D000924:Anticholesteremic Agents; D000499:Allylamine; D000069472:Colesevelam Hydrochloride